Robert Eggertsen

Summary

Affiliation: Sahlgrenska University Hospital
Country: Sweden

Publications

  1. ncbi No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trial
    Robert Eggertsen
    Department of Medicine Primary Health Care, University of Gothenburg, Mölnlycke vårdcentral, Ekdalavägen 2, S 435 30, Molnlycke, Sweden
    BMC Pharmacol Toxicol 13:10. 2012
  2. ncbi Variation in plasma calcium analysis in primary care in Sweden--a multilevel analysis
    Sofia Dalemo
    Dept of Public Health and Community Medicine Primary Health Care, Sahlgrenska academy Gothenburg University, PO Box 454, SE 405 30 Gothenburg, Sweden
    BMC Fam Pract 11:43. 2010
  3. ncbi Effects of treatment with a commercially available St John's Wort product (Movina) on cholesterol levels in patients with hypercholesterolemia treated with simvastatin
    Robert Eggertsen
    Department of Medicine Public Health and Community Medicine Primary Health Care, Goteborg University, Mölnlycke Primary Health Care and Research Unit, Gothenburg, Sweden
    Scand J Prim Health Care 25:154-9. 2007
  4. ncbi Height loss in women caused by vertebral fractures and osteoporosis
    Robert Eggertsen
    Centre of Bone Research, Sahlgrenska Academy Department of Medicine Primary Health Care and Mölnlycke Primary Health Care and Research Centre, Molnlycke, Sweden
    Ups J Med Sci 112:213-9. 2007
  5. ncbi [A study of 56-65 years old persons in Mölnlycke. No association between Helicobacter and heart disease or thyroid disorder]
    Robert Eggertsen
    , ,
    Lakartidningen 99:508-9. 2002
  6. ncbi Hip and fragility fracture prediction by 4-item clinical risk score and mobile heel BMD: a women cohort study
    Daniel Albertsson
    Department of Medicine Public Health and Community Medicine Primary Health Care, Sahlgrenska Academy at Goteborg University, Arvid Wallgrens Backe, Goteborg, Sweden
    BMC Musculoskelet Disord 11:55. 2010
  7. ncbi Can brain natriuretic peptide (BNP) be used as a screening tool in general practice?
    Maria Schaufelberger
    Department of Cardiology, Mölnlycke Primary Health Care and Research Centre, Molnlycke, Sweden
    Scand J Prim Health Care 22:187-90. 2004
  8. ncbi Osteoporosis in a nursing home, determined by the DEXA technique
    Ulla Sallin
    , Department of Primary Healthcare, , G6teborg, Sweden
    Med Sci Monit 11:CR67-70. 2005
  9. ncbi [Acute otitis media is not treated according to recommendations. Survey of treatment patterns in emergency centers and community health centers]
    Anna Lundborg Ander

    Lakartidningen 101:3142-3, 3146. 2004
  10. ncbi [Treatment in the community health centers in accordance with recommendations of the Medical Products Agency. Unsatisfactory weight reduction with orlistat]
    Maria Hedqvist

    Lakartidningen 99:404-5. 2002

Collaborators

Detail Information

Publications11

  1. ncbi No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trial
    Robert Eggertsen
    Department of Medicine Primary Health Care, University of Gothenburg, Mölnlycke vårdcentral, Ekdalavägen 2, S 435 30, Molnlycke, Sweden
    BMC Pharmacol Toxicol 13:10. 2012
    ..The aim of this trial was to investigate the effects of glucosamine on s-cholesterol levels (total s-cholesterol, s-HDL, s-LDL) in primary care patients on treatment with simvastatin or atorvastatin...
  2. ncbi Variation in plasma calcium analysis in primary care in Sweden--a multilevel analysis
    Sofia Dalemo
    Dept of Public Health and Community Medicine Primary Health Care, Sahlgrenska academy Gothenburg University, PO Box 454, SE 405 30 Gothenburg, Sweden
    BMC Fam Pract 11:43. 2010
    ..In this study we aimed to investigate variation of P-Ca analysis between physicians and health care centres (HCCs) in primary care in county of Skaraborg, Sweden...
  3. ncbi Effects of treatment with a commercially available St John's Wort product (Movina) on cholesterol levels in patients with hypercholesterolemia treated with simvastatin
    Robert Eggertsen
    Department of Medicine Public Health and Community Medicine Primary Health Care, Goteborg University, Mölnlycke Primary Health Care and Research Unit, Gothenburg, Sweden
    Scand J Prim Health Care 25:154-9. 2007
    ..To assess the effect of treatment with a St John's Wort product (Movina) on cholesterol levels (total cholesterol, LDL-cholesterol, and HDL-cholesterol) in patients with hypercholesterolemia on treatment with a stable dose of simvastatin...
  4. ncbi Height loss in women caused by vertebral fractures and osteoporosis
    Robert Eggertsen
    Centre of Bone Research, Sahlgrenska Academy Department of Medicine Primary Health Care and Mölnlycke Primary Health Care and Research Centre, Molnlycke, Sweden
    Ups J Med Sci 112:213-9. 2007
    ..To investigate women, with height loss of more than three cm, without earlier diagnosed spinal fractures, for osteoporosis and vertebral fractures...
  5. ncbi [A study of 56-65 years old persons in Mölnlycke. No association between Helicobacter and heart disease or thyroid disorder]
    Robert Eggertsen
    , ,
    Lakartidningen 99:508-9. 2002
  6. ncbi Hip and fragility fracture prediction by 4-item clinical risk score and mobile heel BMD: a women cohort study
    Daniel Albertsson
    Department of Medicine Public Health and Community Medicine Primary Health Care, Sahlgrenska Academy at Goteborg University, Arvid Wallgrens Backe, Goteborg, Sweden
    BMC Musculoskelet Disord 11:55. 2010
    ..We wanted to revalidate a 4-item clinical risk score and evaluate a portable heel bone mineral density (BMD) technique regarding hip and fragility fracture risk among elderly women...
  7. ncbi Can brain natriuretic peptide (BNP) be used as a screening tool in general practice?
    Maria Schaufelberger
    Department of Cardiology, Mölnlycke Primary Health Care and Research Centre, Molnlycke, Sweden
    Scand J Prim Health Care 22:187-90. 2004
    ..To investigate plasma brain natriuretic peptide (p-BNP) in consecutive primary care patients for heart failure screening...
  8. ncbi Osteoporosis in a nursing home, determined by the DEXA technique
    Ulla Sallin
    , Department of Primary Healthcare, , G6teborg, Sweden
    Med Sci Monit 11:CR67-70. 2005
    ....
  9. ncbi [Acute otitis media is not treated according to recommendations. Survey of treatment patterns in emergency centers and community health centers]
    Anna Lundborg Ander

    Lakartidningen 101:3142-3, 3146. 2004
    ..We conclude that penicillin V is first choice of treatment in AOM, that treatment time varies from five to ten days without any underlying reasons and that expectancy was used only in very few cases...
  10. ncbi [Treatment in the community health centers in accordance with recommendations of the Medical Products Agency. Unsatisfactory weight reduction with orlistat]
    Maria Hedqvist

    Lakartidningen 99:404-5. 2002
    ..Total cost for medical staff's working hours was approximately 700 Swedish crowns per kg weight loss. This cost seems rather high in comparison with the unsatisfactory results obtained for the group as a whole...
  11. ncbi Validation of a 4-item score predicting hip fracture and mortality risk among elderly women
    Daniel M Albertsson
    Department of Primary Health Care, Sahlgrenska Academy at Goteborg University, Goteborg, Sweden
    Ann Fam Med 5:48-56. 2007
    ..One in 4 Swedish women experiences a hip fracture, an event that has high concomitant morbidity and mortality. We developed and validated a clinical predictor of fracture and mortality risk, the Fracture and Mortality (FRAMO) Index...